New Product Launch and Seminar at SupplySide East
La Grange, IL (April 7, 2005) – Cognis invites attendees and media at SupplySide East in Baltimore to attend a special Vendorworks presentation, “Evaluating Eye Health Ingredients for Winning Formulations” on Friday, May 6 from 10 to 10:50 a.m. at the Baltimore Convention Center in Room 343.
“Those attending will learn which ingredients provide the strongest marketing opportunities for eye health products,” said Robert Bailey, Global Marketing Manager for Eye Health, Cognis Nutrition & Health. “We will be presenting new consumer data and efficacy information critical to market launch success.” All attendess will receive a special gift.
Cogis will also be highlighting newly published science showing that Tonalin®CLA (Conjugated Linoleic Acid) helps dieters safely keep off lost body fat.
In addition to presenting news on Tonalin® CLA and Xangold® natural lutein esters, managers will be available at Cognis booth 1709-1711 to answer questions on Cognis’ other health-enhancing ingredients including: Betatene® natural mixed carotenoids, Covi-ox®natural antioxidants, Covitol® natural-source vitamin E, Lipoec® alpha lipoic acid, and Vegapure® vegetable sterol esters.
Cognis (www.Cognis.com) is a worldwide supplier of innovative specialty chemicals and nutritional ingredients. It employs about 8,100 people, and has production sites and service centers in 30 countries. The company has dedicated its activities to a high level of sustainability and delivers natural source raw materials and ingredients for food, nutrition and healthcare markets, and the cosmetics, detergents and cleaners industries. Additionally, Cognis provides solutions for a number of other industries, such as coatings and inks, lubricants, textiles and plastics, as well as agriculture and mining. Cognis is owned by private equity funds advised by Permira, GS Capital Partners, and Schroder Ventures Life Sciences. In 2004, Cognis recorded sales of 3.07 billion Euros and an operating profit before depreciation, amortization and exceptional items (EBITDA adjusted) of 362 million Euros.
Cognis Nutrition and Health, a business unit of Cognis Group, offers one of the industry’s largest portfolios of natural-source, health-enhancing ingredients for dietary supplements, functional foods, medical nutrition, pharmaceutical and healthcare products. As a global supplier, Cognis partners with industry leaders to provide science-backed products to meet today’s most pressing consumer health needs. Cognis also manufactures emulsifiers, emulsifier-based compounds, and numerous other specialty products for the food industry worldwide.